CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for EMI Holding, Inc. is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

EMI Holding, Inc.
21250 Hawthorne Boulevard
Suite 800
Phone: (310) 214-0065p:310 214-0065 Torrance, CA  90503-5513  United States Fax: (302) 636-5454f:302 636-5454

Business Summary
EMI Holding, Inc., formerly Emmaus Life Sciences, Inc., is a commercial-stage biopharmaceutical company. The Company is engaged in discovering, developing, and commercializing treatments and therapies for orphan diseases. It's lead product candidate Endari is a pharmaceutical grade L-glutamine oral powder. It has completed Phase three clinical trial for the treatment of sickle cell disease.

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
IRA CQ
Score
Moody's
Rating
Fitch
Rating
DBRS
Rating
Morningstar
Rating
-Yes-Yes-----

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
3/31/201912/31/2018YesYes---

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Chairman of the Board, Chief Executive Officer YutakaNiihara 59 1/1/2016 5/3/2011
President, Chief Administrative Officer Lan T.Tran 39 9/27/2018 5/3/2011
Vice Chairman of the Board, Chief Operating Officer Willis C.Lee 58 7/16/2018 5/3/2011
6 additional Officers and Directors records available in full report.

Business Names
Business Name
Emmaus Life Sciences, Co. Ltd
Emmaus Medical Europe, Ltd.
Emmaus Medical Europe, Ltd.
Emmaus Medical Japan, Inc.
Emmaus Medical, Inc.
Newfield Nutrition Corp.

General Information
Number of Employees: 16 (As of 12/31/2013)
Outstanding Shares: 36,051,394 (As of 5/10/2019)
Shareholders: 326
Federal Tax Id: 412254389
Fax Number: (302) 636-5454


Copyright © 2019 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Thursday, November 14, 2019